Richard Hermida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Richard Hermida has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Hillary Samples
Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA; School of Public Health, Rutgers University, New Brunswick, NJ, USA
2 shared publications - Peter Treitler
Boston University School of Social Work, Boston, MA, USA
2 shared publications - Elizabeth M. Stone
Center for Health Services Research, Institute for Health, Health Care Policy, and Aging Research, Rutgers University , New Brunswick, NJ 08901
1 shared publication - Jennifer Miles
Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
1 shared publication - Stephen Crystal
Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA; School of Social Work, Rutgers University, New Brunswick, NJ, USA
1 shared publication - Stephen Crystal
Institute for Health, Health Care Policy & Aging Research, Rutgers University, New Brunswick, USA
1 shared publication
Latest Publications
- 1 June 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 72 (1) , 108455
Opioid use disorder, pharmacotherapy, and overdose among Medicare disability beneficiaries from 2008-2021
- 1 June 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 72 (1) , 108455
Opioid use disorder, pharmacotherapy, and overdose among Medicare disability beneficiaries from 2008-2021
- 6 January 2023
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 38 (8) , 1862-1870
Association of a State Prescribing Limits Policy with Opioid Prescribing and Long-term Use: an Interrupted Time Series Analysis
Background Prescription opioids were a major initial driver of the opioid crisis. States have attempted to reduce overprescribing by enacting policies that limit opioid prescriptions, but the impacts of such policies on new prescribing and subsequent transitions to long-term use are not fully understood. Objective To examine the association of implementation of a state prescribing limits policy with opioid prescribing and transitions to long-term opioid use. Design Interrupted time series analyses assessing trends in new opioid prescriptions and long-term use before and after policy implementation. Patients A total of 130,591 New Jersey Medicaid enrollees ages 18–64 who received an initial opioid prescription from January 2014 to December 2019. Interventions New Jersey’s opioid prescribing limit policy implemented in March 2017. Main Measures Total new opioid prescriptions, percentage of new prescriptions with >5 days’ supply, and transition to long-term opioid use, defined as having opioid supply on day 90 after the initial prescription. Key Results Policy implementation was associated with a significant monthly increase in new opioid prescriptions of 0.86 per 10,000 enrollees, halving the pre-policy decline in the prescribing rate. Among new opioid prescriptions, the percentage with >5 days’ supply decreased by about 1 percentage point (−0.76 percentage points, 95% CI −0.89, −0.62) following policy implementation. However, policy implementation was associated with a significant monthly increase in the rate of initial prescriptions with supply on day 90 (9.95 per 10,000 new prescriptions, 95% CI 4.80, 15.11) that reversed the downward pre-implementation trend. Conclusions The New Jersey policy was associated with a reduction in initial prescriptions with >5 days’ supply, but not with an overall decline in new opioid prescriptions or in the rate at which initial prescriptions led to long-term use. Given their only modest benefits, policymakers and clinicians should carefully weigh potential unintended consequences of strict prescribing limits.
- 6 January 2023
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 38 (8) , 1862-1870
Association of a State Prescribing Limits Policy with Opioid Prescribing and Long-term Use: an Interrupted Time Series Analysis
Background Prescription opioids were a major initial driver of the opioid crisis. States have attempted to reduce overprescribing by enacting policies that limit opioid prescriptions, but the impacts of such policies on new prescribing and subsequent transitions to long-term use are not fully understood. Objective To examine the association of implementation of a state prescribing limits policy with opioid prescribing and transitions to long-term opioid use. Design Interrupted time series analyses assessing trends in new opioid prescriptions and long-term use before and after policy implementation. Patients A total of 130,591 New Jersey Medicaid enrollees ages 18–64 who received an initial opioid prescription from January 2014 to December 2019. Interventions New Jersey’s opioid prescribing limit policy implemented in March 2017. Main Measures Total new opioid prescriptions, percentage of new prescriptions with >5 days’ supply, and transition to long-term opioid use, defined as having opioid supply on day 90 after the initial prescription. Key Results Policy implementation was associated with a significant monthly increase in new opioid prescriptions of 0.86 per 10,000 enrollees, halving the pre-policy decline in the prescribing rate. Among new opioid prescriptions, the percentage with >5 days’ supply decreased by about 1 percentage point (−0.76 percentage points, 95% CI −0.89, −0.62) following policy implementation. However, policy implementation was associated with a significant monthly increase in the rate of initial prescriptions with supply on day 90 (9.95 per 10,000 new prescriptions, 95% CI 4.80, 15.11) that reversed the downward pre-implementation trend. Conclusions The New Jersey policy was associated with a reduction in initial prescriptions with >5 days’ supply, but not with an overall decline in new opioid prescriptions or in the rate at which initial prescriptions led to long-term use. Given their only modest benefits, policymakers and clinicians should carefully weigh potential unintended consequences of strict prescribing limits.